Zhang, Yurun http://orcid.org/0000-0001-6437-1773
Roos, Martina
Himburg, Heather
Termini, Christina M. http://orcid.org/0000-0002-1831-1347
Quarmyne, Mamle
Li, Michelle
Zhao, Liman
Kan, Jenny
Fang, Tiancheng
Yan, Xiao
Pohl, Katherine
Diers, Emelyne
Jin Gim, Hyo
Damoiseaux, Robert
Whitelegge, Julian http://orcid.org/0000-0003-2763-7733
McBride, William
Jung, Michael E.
Chute, John P. http://orcid.org/0000-0002-8841-0527
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI067769)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL086998, U54-HL119893)
California Institute for Regenerative Medicine (LA1-08014, DISC2-09624)
Article History
Received: 14 December 2017
Accepted: 18 July 2019
First Online: 14 August 2019
Competing interests
: Authors M.R., M.E.J. and J.P.C. are inventors on patent applications US 16/304,427 and EP 17803701.6, and PCT application US 2018/063,074, which are relevant to the use of PTPσ inhibitors described here. All other authors declare no competing interests.